On Friday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) opened lower -4.10% from the last session, before settling in for the closing price of $1.22. Price fluctuations for SLS have ranged from $0.50 to $1.72 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 22.63% over the last five years. Company’s average yearly earnings per share was noted 59.95% at the time writing. With a float of $70.08 million, this company’s outstanding shares have now reached $70.38 million.
The firm has a total of 16 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
SELLAS Life Sciences Group Inc (SLS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of SELLAS Life Sciences Group Inc is 0.43%, while institutional ownership is 7.65%.
SELLAS Life Sciences Group Inc (SLS) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.25 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.03) by -0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 59.95% per share during the next fiscal year.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Check out the current performance indicators for SELLAS Life Sciences Group Inc (SLS). In the past quarter, the stock posted a quick ratio of 2.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Analysing the last 5-days average volume posted by the [SELLAS Life Sciences Group Inc, SLS], we can find that recorded value of 1.08 million was better than the volume posted last year of 1.07 million. As of the previous 9 days, the stock’s Stochastic %D was 21.74%. Additionally, its Average True Range was 0.09.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 29.11%, which indicates a significant increase from 12.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.96% in the past 14 days, which was higher than the 51.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2260, while its 200-day Moving Average is $1.2333. Now, the first resistance to watch is $1.2133. This is followed by the second major resistance level at $1.2567. The third major resistance level sits at $1.2833. If the price goes on to break the first support level at $1.1433, it is likely to go to the next support level at $1.1167. Now, if the price goes above the second support level, the third support stands at $1.0733.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
There are currently 70,382K shares outstanding in the company with a market cap of 78.97 million. Presently, the company’s annual sales total 0 K according to its annual income of -37,340 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,110 K.
